Tenet Healthcare Corporation
| Security | THC / Tenet Healthcare Corporation |
| Insider | James L Bierman |
This page shows the track record and history of BIERMAN JAMES L
insider trades in Tenet Healthcare Corporation. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by James L Bierman in THC / Tenet Healthcare Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by James L Bierman in THC / Tenet Healthcare Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | 2026-05-22 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 1,333 | 36,604 | ||||||
| 2025-05-30 | 2025-05-29 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 170.0000 | -4,613 | -784 | 35,271 | ||||
| 2025-05-28 | 2025-05-27 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 165.7200 | -1,551 | -257 | 39,884 | ||||
| 2025-05-27 | 2025-05-23 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 160.0000 | -5,000 | -800 | 41,435 | ||||
| 2025-05-27 | 2025-05-23 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 159.3500 | -8,836 | -1,408 | 46,435 | ||||
| 2025-05-27 | 2025-05-23 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 1,551 | 55,271 | ||||||
| 2023-06-23 | 2023-05-26 | 4/A | BIERMAN JAMES L | THC | Common Stock | D | 3,682 | 53,720 | ||||||
| 2023-05-30 | 2023-05-26 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 2,846 | 52,884 | ||||||
| 2022-05-11 | 2022-05-09 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 3,836 | 50,038 | ||||||
| 2021-05-11 | 2021-05-07 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 3,960 | 46,202 | ||||||
| 2020-06-02 | 2020-05-29 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 11,139 | 42,242 | ||||||
| 2019-05-07 | 2019-05-03 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 10,817 | 31,103 | ||||||
| 2018-05-08 | 2018-05-04 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 7,439 | 20,286 | ||||||
| 2017-11-02 | 2017-10-31 | 4 | BIERMAN JAMES L | THC | Common Stock | D | 12,847 | 12,847 |
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)
